Literature DB >> 8546214

Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques.

H Fukumoto1, A Asami-Odaka, N Suzuki, H Shimada, Y Ihara, T Iwatsubo.   

Abstract

Two distinct species of amyloid beta protein (A beta) with different C-termini, A beta 42(43) and A beta 40, are deposited in senile plaques (SP) of Alzheimer's disease (AD), with the former being far predominant. To investigate whether A beta 42(43) also predominates over A beta 40 in normal aging, we examined by immunocytochemistry the C-termini of A beta in SP in the brains of non-demented aged individuals and compared the results with those in AD. Virtually all SP were A beta 42(43)-positive; of these 12% in non-demented aged individuals and 25% in AD patients (mean of three areas examined) were also A beta 40-positive. In both the AD and non-demented groups, 2/3 of the A beta 40-positive SP were typical cored SP. These results indicate that A beta 42(43) is the predominant species deposited in SP in normal aging, and there is no qualitative difference in terms of the C-terminus of A beta in the parenchymal amyloid deposition between normal aging and AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546214      PMCID: PMC1861616     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer's disease.

Authors:  M Imagawa; S Naruse; S Tsuji; A Fujioka; H Yamaguchi
Journal:  Lancet       Date:  1992-09-12       Impact factor: 79.321

2.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.

Authors:  M Mullan; F Crawford; K Axelman; H Houlden; L Lilius; B Winblad; L Lannfelt
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

Review 3.  Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

Authors:  J T Jarrett; P T Lansbury
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

4.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  J T Jarrett; E P Berger; P T Lansbury
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

5.  The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

Authors:  B T Hyman; K Marzloff; P V Arriagada
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

6.  Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Authors:  P Seubert; C Vigo-Pelfrey; F Esch; M Lee; H Dovey; D Davis; S Sinha; M Schlossmacher; J Whaley; C Swindlehurst
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

7.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

8.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

Authors:  D L Miller; I A Papayannopoulos; J Styles; S A Bobin; Y Y Lin; K Biemann; K Iqbal
Journal:  Arch Biochem Biophys       Date:  1993-02-15       Impact factor: 4.013

9.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

Authors:  A E Roher; J D Lowenson; S Clarke; C Wolkow; R Wang; R J Cotter; I M Reardon; H A Zürcher-Neely; R L Heinrikson; M J Ball
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

10.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

Authors:  A E Roher; J D Lowenson; S Clarke; A S Woods; R J Cotter; E Gowing; M J Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

View more
  24 in total

1.  Accumulation of pro-apolipoprotein A-II in mouse senile amyloid fibrils.

Authors:  K Higuchi; K Kogishi; J Wang; C Xia; T Chiba; T Matsushita; M Hosokawa
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

3.  Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.

Authors:  R-M Liu; T van Groen; A Katre; D Cao; I Kadisha; C Ballinger; L Wang; S L Carroll; L Li
Journal:  Neurobiol Aging       Date:  2009-07-14       Impact factor: 4.673

Review 4.  Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Authors:  Anders Lönneborg
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 5.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

6.  Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Authors:  R Thangavel; D Stolmeier; X Yang; P Anantharam; A Zaheer
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

Review 7.  Causes of Alzheimer's disease.

Authors:  D G Munoz; H Feldman
Journal:  CMAJ       Date:  2000-01-11       Impact factor: 8.262

8.  Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.

Authors:  H Funato; M Yoshimura; K Kusui; A Tamaoka; K Ishikawa; N Ohkoshi; K Namekata; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.

Authors:  Ghiam Yamin; David B Teplow
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

10.  Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.

Authors:  D M Mann; T Iwatsubo; Y Ihara; N J Cairns; P L Lantos; N Bogdanovic; L Lannfelt; B Winblad; M L Maat-Schieman; M N Rossor
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.